Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mendelics | RCV000986578 | SCV001135600 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
| Color Diagnostics, |
RCV001188477 | SCV001355548 | likely benign | Cardiomyopathy | 2018-12-11 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000986578 | SCV002483121 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-03-18 | criteria provided, single submitter | clinical testing | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV002222429 | SCV002500581 | likely benign | not specified | 2022-03-22 | criteria provided, single submitter | clinical testing | Variant summary: RYR2 c.4693C>G (p.Pro1565Ala) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 236230 control chromosomes, predominantly at a frequency of 0.0009 within the South Asian subpopulation in the gnomAD database. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 26-fold of the estimated maximal expected allele frequency for a pathogenic variant in RYR2 causing Catecholaminergic Polymorphic Ventricular Tachycardia phenotype (3.4e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.4693C>G has been reported in the literature in an individual with arrhythmogenic right ventricular dysplasia/cardiomyopathy (te Riele_2013). This report does not provide unequivocal conclusions about association of the variant with Catecholaminergic Polymorphic Ventricular Tachycardia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely benign, and as VUS. Based on the evidence outlined above, the variant was classified as likely benign. |